Non small cell lung cancer classification: Difference between revisions
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{SC}} {{MV}} | {{CMG}}; {{AE}} {{SC}} {{MV}} | ||
==Overview== | ==Overview== | ||
Non-small cell lung cancer may be classified according to the WHO histological classification system into 3 main types: squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. Other less common subtypes, include: adenosquamous lung carcinoma, pulmonary sarcomatoid carcinoma, carcinoid tumors of lung, and carcinomas of the lung of salivary gland type.<ref name="NSCLC"> Non-Small Cell Lung Cancer Treatment –for health professionals. National Cancer Institute – Physician Data Query PDQ. http://www.cancer.gov/types/lung/hp/non-small-cell-lung-treatment-pdq#link/_361_toc Accessed on February 3, 2016.</ref> | Non-small cell lung cancer may be classified according to the [[World Health Organization|WHO histological classification system]] into 3 main types: [[Squamous cell lung cancer|squamous cell carcinoma]], [[Adenocarcinoma of the lung|lung adenocarcinoma]], and [[Large cell carcinoma of the lung|large cell carcinoma]]. Other less common subtypes, include: adenosquamous lung carcinoma, pulmonary sarcomatoid carcinoma, carcinoid tumors of lung, and carcinomas of the lung of salivary gland type.<ref name="NSCLC">Non-Small Cell Lung Cancer Treatment –for health professionals. National Cancer Institute – Physician Data Query PDQ. http://www.cancer.gov/types/lung/hp/non-small-cell-lung-treatment-pdq#link/_361_toc Accessed on February 3, 2016.</ref> | ||
==Classification== | ==Classification== | ||
Line 9: | Line 9: | ||
*The table below summarizes the WHO histological classification system for non small cell lung cancer.<ref>{{cite book | last = Travis | first = William | title = Pathology and genetics of tumours of the lung, pleura, thymus, and heart | publisher = IARC Press | location = Lyon | year = 2004 | isbn = 9283224183 }}</ref><ref name="pmid16640802">{{cite journal| author=Raz DJ, He B, Rosell R, Jablons DM| title=Bronchioloalveolar carcinoma: a review. | journal=Clin Lung Cancer | year= 2006 | volume= 7 | issue= 5 | pages= 313-22 | pmid=16640802 | doi=10.3816/CLC.2006.n.012 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16640802 }} </ref> | *The table below summarizes the WHO histological classification system for non small cell lung cancer.<ref>{{cite book | last = Travis | first = William | title = Pathology and genetics of tumours of the lung, pleura, thymus, and heart | publisher = IARC Press | location = Lyon | year = 2004 | isbn = 9283224183 }}</ref><ref name="pmid16640802">{{cite journal| author=Raz DJ, He B, Rosell R, Jablons DM| title=Bronchioloalveolar carcinoma: a review. | journal=Clin Lung Cancer | year= 2006 | volume= 7 | issue= 5 | pages= 313-22 | pmid=16640802 | doi=10.3816/CLC.2006.n.012 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16640802 }} </ref> | ||
{|style="border: 0px; font-size: 90%; margin: 3px; width: 1000px" align=center | {| style="border: 0px; font-size: 90%; margin: 3px; width: 1000px" align="center" | ||
!style="padding: 5px 5px; background: #4479BA; font-weight: bold; text-align:center;" colspan="3"|{{fontcolor|#FFF|''WHO histological classification system'' <br><SMALL>Adapted from WHO/IARC (2006) <ref name="radiowiki"> Tumors of the Lung. IARC/WHO https://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb10/bb10-chap1.pdf Accessed on February 22, 2016 </ref></SMALL>}} | ! style="padding: 5px 5px; background: #4479BA; font-weight: bold; text-align:center;" colspan="3" |{{fontcolor|#FFF|''WHO histological classification system'' <br><SMALL>Adapted from WHO/IARC (2006) <ref name="radiowiki"> Tumors of the Lung. IARC/WHO https://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb10/bb10-chap1.pdf Accessed on February 22, 2016 </ref></SMALL>}} | ||
|valign=top| | | valign="top" | | ||
|+ | |+ | ||
|- | |- | ||
| style="background: #4479BA; width: 300px;"|{{fontcolor|#FFF|''' Main types'''}} | | style="background: #4479BA; width: 300px;" |{{fontcolor|#FFF|''' Main types'''}} | ||
| style="background: #4479BA; width: 300px;"|{{fontcolor|#FFF|''' Subtypes'''}} | | style="background: #4479BA; width: 300px;" |{{fontcolor|#FFF|''' Subtypes'''}} | ||
| style="background: #4479BA; width: 300px;"|{{fontcolor|#FFF|''' Prevalence'''}} | | style="background: #4479BA; width: 300px;" |{{fontcolor|#FFF|''' Prevalence'''}} | ||
|- | |- | ||
|style="padding: 0 5px; background: #DCDCDC"| '''Adenocarcinoma''' | | style="padding: 0 5px; background: #DCDCDC" | '''Adenocarcinoma''' | ||
|style="padding: 5px 5px; background: #F5F5F5;"| | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Adenocarcinoma, mixed | *Adenocarcinoma, mixed | ||
*Acinar adenocarcinoma | *Acinar adenocarcinoma | ||
Line 33: | Line 33: | ||
*Signet ring adenocarcinoma | *Signet ring adenocarcinoma | ||
*Clear cell adenocarcinoma | *Clear cell adenocarcinoma | ||
|style="padding: 5px 5px; background: #F5F5F5;"| | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*40% of lung cancers | *40% of lung cancers | ||
|- | |- | ||
|style="padding: 0 5px; background: #DCDCDC"| '''Squamous cell carcinoma''' | | style="padding: 0 5px; background: #DCDCDC" | '''Squamous cell carcinoma''' | ||
|style="padding: 5px 5px; background: #F5F5F5;"| | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Papillary | *Papillary | ||
*Clear cell | *Clear cell | ||
*Small cell | *Small cell | ||
*Basaloid | *Basaloid | ||
|style="padding: 5px 5px; background: #F5F5F5;"| | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*25% of lung cancers | *25% of lung cancers | ||
|- | |- | ||
|style="padding: 0 5px; background: #DCDCDC"| '''Large cell carcinoma''' | | style="padding: 0 5px; background: #DCDCDC" | '''Large cell carcinoma''' | ||
|style="padding: 5px 5px; background: #F5F5F5;"| | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Large cell neuroendocrine carcinoma | *Large cell neuroendocrine carcinoma | ||
*Basaloid carcinoma | *Basaloid carcinoma | ||
Line 52: | Line 52: | ||
*Clear cell carcinoma | *Clear cell carcinoma | ||
*Large cell carcinoma with rhabdoid phenotype | *Large cell carcinoma with rhabdoid phenotype | ||
|style="padding: 5px 5px; background: #F5F5F5;"| | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*10% of lung cancer | *10% of lung cancer | ||
|- | |- | ||
|style="background: #4479BA; width: 100px; text-align:center;" colspan="3"|{{fontcolor|#FFF|'''Less common types'''}} | | style="background: #4479BA; width: 100px; text-align:center;" colspan="3" |{{fontcolor|#FFF|'''Less common types'''}} | ||
|- | |- | ||
|style="padding: 0 5px; background: #DCDCDC" | '''Adenosquamous carcinoma''' | | style="padding: 0 5px; background: #DCDCDC" | '''Adenosquamous carcinoma''' | ||
|style="padding: 5px 5px; background: #F5F5F5;"| | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*No subtypes | *No subtypes | ||
|style="padding: 5px 5px; background: #F5F5F5;"| | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Less than 5% | *Less than 5% | ||
|- | |- | ||
|style="padding: 0 5px; background: #DCDCDC" | '''Sarcomatoid carcinoma''' | | style="padding: 0 5px; background: #DCDCDC" | '''Sarcomatoid carcinoma''' | ||
|style="padding: 5px 5px; background: #F5F5F5;"| | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Pleomorphic carcinoma | *Pleomorphic carcinoma | ||
*Spindle cell carcinoma | *Spindle cell carcinoma | ||
Line 70: | Line 70: | ||
*Carcinosarcoma | *Carcinosarcoma | ||
*Pulmonary blastoma | *Pulmonary blastoma | ||
|style="padding: 5px 5px; background: #F5F5F5;"| | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Less than 5% | *Less than 5% | ||
|- | |- | ||
|style="padding: 0 5px; background: #DCDCDC" | '''Carcinoid tumor''' | | style="padding: 0 5px; background: #DCDCDC" | '''Carcinoid tumor''' | ||
|style="padding: 5px 5px; background: #F5F5F5;"| | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Typical carcinoid | *Typical carcinoid | ||
*Atypical carcinoid | *Atypical carcinoid | ||
|style="padding: 5px 5px; background: #F5F5F5;"| | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Less than 5% | *Less than 5% | ||
|- | |- | ||
|style="padding: 0 5px; background: #DCDCDC" | '''Salivary gland tumor''' | | style="padding: 0 5px; background: #DCDCDC" | '''Salivary gland tumor''' | ||
|style="padding: 5px 5px; background: #F5F5F5;"| | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Mucoepidermoid carcinoma | *Mucoepidermoid carcinoma | ||
*Adenoid cystic carcinoma | *Adenoid cystic carcinoma | ||
*Epithelial-myoepithelial carcinoma | *Epithelial-myoepithelial carcinoma | ||
|style="padding: 5px 5px; background: #F5F5F5;"| | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Less than 5% | *Less than 5% | ||
|} | |} | ||
==References== | ==References== |
Revision as of 20:12, 22 February 2016
Non Small Cell Lung Cancer Microchapters |
Differentiating Non Small Cell Lung Cancer from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Non small cell lung cancer classification On the Web |
American Roentgen Ray Society Images of Non small cell lung cancer classification |
Directions to Hospitals Treating Non small cell carcinoma of the lung |
Risk calculators and risk factors for Non small cell lung cancer classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2] Maria Fernanda Villarreal, M.D. [3]
Overview
Non-small cell lung cancer may be classified according to the WHO histological classification system into 3 main types: squamous cell carcinoma, lung adenocarcinoma, and large cell carcinoma. Other less common subtypes, include: adenosquamous lung carcinoma, pulmonary sarcomatoid carcinoma, carcinoid tumors of lung, and carcinomas of the lung of salivary gland type.[1]
Classification
- There are 3 main types of non–small cell lung cancer: adenocarcinoma, squamous cell carcinoma and large cell carcinoma.
- The table below summarizes the WHO histological classification system for non small cell lung cancer.[2][3]
WHO histological classification system Adapted from WHO/IARC (2006) [4] |
|||
---|---|---|---|
Main types | Subtypes | Prevalence | |
Adenocarcinoma |
|
| |
Squamous cell carcinoma |
|
| |
Large cell carcinoma |
|
| |
Less common types | |||
Adenosquamous carcinoma |
|
| |
Sarcomatoid carcinoma |
|
| |
Carcinoid tumor |
|
| |
Salivary gland tumor |
|
|
References
- ↑ Non-Small Cell Lung Cancer Treatment –for health professionals. National Cancer Institute – Physician Data Query PDQ. http://www.cancer.gov/types/lung/hp/non-small-cell-lung-treatment-pdq#link/_361_toc Accessed on February 3, 2016.
- ↑ Travis, William (2004). Pathology and genetics of tumours of the lung, pleura, thymus, and heart. Lyon: IARC Press. ISBN 9283224183.
- ↑ Raz DJ, He B, Rosell R, Jablons DM (2006). "Bronchioloalveolar carcinoma: a review". Clin Lung Cancer. 7 (5): 313–22. doi:10.3816/CLC.2006.n.012. PMID 16640802.
- ↑ Tumors of the Lung. IARC/WHO https://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb10/bb10-chap1.pdf Accessed on February 22, 2016